# OnCo record paper-conroy-folfirinox-pancreatic-nejm-2011 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-conroy-folfirinox-pancreatic-nejm-2011/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-conroy-folfirinox-pancreatic-nejm-2011" ;
  schema:name "Conroy 2011: FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer (PRODIGE 4/ACCORD 11)"@en ;
  schema:description "A four-drug chemotherapy combination gave fit patients with metastatic pancreatic cancer clearly longer survival than the standard gemcitabine, the first real improvement in the disease in over a decade, at the cost of more side effects."@en ;
  schema:url <https://onco.cc/key-papers/paper-conroy-folfirinox-pancreatic-nejm-2011/> ;
  schema:dateModified "2026-09-08"^^xsd:date ;
  schema:citation <https://doi.org/10.1056/NEJMoa1011923>, <https://clinicaltrials.gov/study/NCT00112658> ;
  schema:sameAs <https://doi.org/10.1056/NEJMoa1011923> ;
  schema:datePublished "2011"^^xsd:gYear ;
  schema:author "Conroy T, Desseigne F, Ychou M, et al." ;
  onco:related <https://onco.cc/key-papers/paper-napoli-1-nanoliposomal-irinotecan-lancet-2016/> ;
  onco:cancers <https://onco.cc/cancers/pancreatic/> ;
  onco:drugs <https://onco.cc/drugs/oxaliplatin/>, <https://onco.cc/drugs/irinotecan/>, <https://onco.cc/drugs/fluorouracil/>, <https://onco.cc/drugs/gemcitabine/> ;
  onco:terms <https://onco.cc/terms/os/>, <https://onco.cc/terms/pfs/>, <https://onco.cc/terms/febrile-neutropenia/> ;
  onco:trials <https://onco.cc/trials/prodige-24/> ;
  onco:people <https://onco.cc/people/thierry-conroy/> .